Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs) Source: Eur Respir J 2001; 18: Suppl. 33, 79s Year: 2001
Recruitment and functions of pulmonary intravascular macrophages (PIMs) in biliary cirrhosis Source: Eur Respir J 2005; 26: Suppl. 49, 552s Year: 2005
Different expression of pro- and antiinflammatory cytokines in chlamydia pneumoniae infected blood monocytes and alveolar macrophages from COPD patients and healthy volunteers Source: Eur Respir J 2002; 20: Suppl. 38, 220s Year: 2002
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients. Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Pulmonary intravascular macrophages (PIMs) are recruited following exposure to swine barn air and enhance susceptibility to acute lung inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 347s Year: 2003
Effect of JQ-1 on monocyte-derived macrophage (MDM) phagocytosis of bacteria and cytokine release Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Pro-inflammatory / anti-inflammatory capacity of lymphocyte cells in COPD Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019
Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002
Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Endotoxin-induced IL-17 release by murine T-lymphocytes: interactions with airway macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001
BALF phospholipids and cytokines released by alveolar macrophages in the differential diagnosis of pulmonary sarcoidosis and tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008
Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014
Alveolar macrophage oxidative and pro-inflammatory cytokine activity in lung sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 332s Year: 2005
Neutrophil extracellular traps promoted alveolar macrophages pyroptosis in LPS induced ALI/ARDS Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
Strong increase of proinflammatory blood monocytes in active pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 355s Year: 2004
LSC - 2018 - Differential effect of ARDS on alveolar macrophage efferocytosis compared to bacterial phagocytosis Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018